CompaniesLigoCyte Pharmaceuticals

LigoCyte Pharmaceuticals

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

121

By Phase

PHASE1: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
Today
NCT01435811
Hover over trial bars to see details

Recent Trials

NCT01435811Collaborator
Dose Range Evaluation of Norovirus Challenge Pool (GII.4, CIN-1)
PHASE1Completed
60 participants
Started: Aug 31, 2011 · Completed: Nov 30, 2012
NCT00806962Lead Sponsor
Phase 1 Norwalk Vaccine Study
PHASE1Completed
61 participants
Started: Nov 30, 2008 · Completed: Oct 31, 2009
Funding History (5)
D
Jun 28, 2012
Filing
D
Jun 21, 2011
Filing
D/A
May 28, 2010
Filing
D
Apr 22, 2010
Filing
D/A
Aug 14, 2009
Filing
Related Companies
Takeda Oct 2012----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired